PMI launches IQOS pilot programme in Austin, Texas

Oct.22.2024
PMI launches IQOS pilot programme in Austin, Texas
Philip Morris International (PMI) launches an IQOS pilot programme in Austin, Texas, designed to help smokers quit conventional cigarettes.

Philip Morris International (PMI) is launching a pilot programme for its IQOS heated tobacco device in Austin, Texas, KXAN reported on 21 October. The initiative aims to help smokers switch from traditional cigarettes by offering a less harmful alternative.

 

Although the company has been selling HTP products in international markets, this pilot program in Austin marks its first entry into the US market.

 

Nearly 8% of high school students currently use e-cigarettes, according to a survey by the Centers for Disease Control and Prevention. The company's CEO in the US, Stacey Kennedy, said that IQOS is not and will never be marketed to anyone under the age of 21. She added that their research shows that almost no non-smokers start using IQOS.

 

"Our marketing is only aimed at current nicotine or traditional tobacco users. If you are already a nicotine user, especially if you are unable to quit, switching to a better product would be a better choice."

 

PMI has indicated that it will conduct research and focus groups in Austin before making IQOS available to the public.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | ON! PLUS: Breakdown of Six FDA-PMTA-Authorized Nicotine Pouches—6/9 mg Strengths, Slim Format, and Traditional Flavours
Product | ON! PLUS: Breakdown of Six FDA-PMTA-Authorized Nicotine Pouches—6/9 mg Strengths, Slim Format, and Traditional Flavours
The U.S. FDA has added six ON!® PLUS nicotine pouch products to its list of Marketing Granted Order (MGO) authorizations. Based on 2Firsts’ review, the approved products feature a highly standardized configuration in terms of format, nicotine strength, and flavour portfolio, primarily focusing on 6 mg and 9 mg strengths and traditional variants such as mint, wintergreen, and tobacco—reflecting a clear compliance-oriented approach.
Dec.22 by 2FIRSTS.ai
AIRSCREAM Solidifies South African Leadership & Championing Truth in Vaping
AIRSCREAM Solidifies South African Leadership & Championing Truth in Vaping
As South Africa’s leading lifestyle vaping brand, AIRSCREAM is accelerating its regional growth strategy with the launch of its bold new initiative, “Trust ML, Not Puff.” The campaign calls for factual, millilitre (ml)-based transparency across the vaping industry, directly confronting misleading puff-count marketing practices and promoting clear, standardised information that reflects the true value and capacity of vaping products.
Nov.28
WHO Chief Warns of E-Cigarette Threat to Youth as COP11 Opens in Geneva
WHO Chief Warns of E-Cigarette Threat to Youth as COP11 Opens in Geneva
More than 1,400 delegates from 162 Parties convened in Geneva on November 17 for the Eleventh Session of the Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (WHO FCTC). WHO Director-General Tedros Adhanom Ghebreyesus opened the session with a stark warning: tobacco and nicotine companies are targeting schools as the “new front line” to recruit a generation of addicts through e-cigarettes and nicotine pouches.
Nov.18 by 2FIRSTS.ai
Lao Shuts Down Nearly 300 Online Vape Stores in Joint Crackdown with WHO and Meta
Lao Shuts Down Nearly 300 Online Vape Stores in Joint Crackdown with WHO and Meta
In a coordinated effort with the World Health Organization (WHO) and Meta, the Lao Ministry of Health has taken 288 online e-cigarette stores with more than 759,599 members offline, reinforcing the country’s total ban on e-cigarettes under the National Tobacco Control Law.
Nov.20 by 2FIRSTS.ai
Kansas, U.S.: Attorney General issues alert on China-made “smart vapes” targeting children
Kansas, U.S.: Attorney General issues alert on China-made “smart vapes” targeting children
On Jan. 10, Kansas Attorney General Kris Kobach issued a consumer alert warning Kansans about dangerous vaping products from China marketed as “smart vapes.” The alert says these devices let children use games, social media, Bluetooth, music and more while simultaneously inhaling unregulated materials, and describes them as designed to entice teens and conceal their nature from parents.
Jan.12 by 2FIRSTS.ai
Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer
Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer
Organigram Global has named James Yamanaka, previously Global Head of Strategy at British American Tobacco (BTI), as its new CEO. His appointment is expected to take effect around January 15, 2026, and he will also join the company’s board. Yamanaka brings more than 20 years of strategic and managerial experience from roles across Europe and Asia at BTI.
Nov.26